PF-Atlas › Clinical Trials › NCT03435939
Effect of Losartan in Cystic Fibrosis -NIH Grant #133240
Losartan · Early Phase 1
Registry ID
NCT03435939
Phase
Early Phase 1
Status
Completed
Drug / intervention
Losartan
Sponsor
University of Kansas Medical Center
Start
2022-02-15
Enrollment
13
Locations
1
About this trial
The goal of this study is to execute a small clinical proof of concept trial: To examine the effects of losartan on mucociliary clearance (MCC) in patients not eligible for CFTR rescue therapies
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT03435939 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.